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Abstract
An adverse maternal environment (AME) predisposes adult
offspring toward cognitive impairment in humans and mice.
However, the underlying mechanisms remain poorly understood. Epigenetic changes in response to environmental exposure may be critical drivers of this change. Epigenetic regulators, including microRNAs, have been shown to affect
cognitive function by altering hippocampal neurogenesis
which is regulated in part by brain-derived neurotropic factor (BDNF). We sought to investigate the effects of AME on
miR profile and their epigenetic characteristics, as well as
neurogenesis and BDNF expression in mouse hippocampus.
Using our mouse model of AME which is composed of maternal Western diet and prenatal environmental stress, we
found that AME significantly increased hippocampal miR10b-5p levels. We also found that AME significantly decreased DNA methylation and increased accumulations of
active histone marks H3 lysine (K) 4me3, H3K14ac, and
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 3K36me3 at miR-10b promoter. Furthermore, AME signifiH
cantly decreased hippocampal neurogenesis by decreasing
cell numbers of Ki67+ (proliferation marker), NeuroD1+ (neuronal differentiation marker), and NeuN+ (mature neuronal
marker) in the dentate gyrus (DG) region concurrently with
decreased hippocampal BDNF protein levels. We speculate
that the changes in epigenetic profile at miR-10b promoter
may contribute to upregulation of miR-10b-5p and subsequently lead to decreased BDNF levels in a model of impaired offspring hippocampal neurogenesis and cognition
in mice.
© 2021 The Author(s)
Published by S. Karger AG, Basel

Introduction

Adverse maternal environment (AME) and the consumption of a Western diet (WD) in early childhood increases the risk for cognitive impairment later in life in
both humans [1–3] and animal models [4–6]. Indeed, using our mouse model we have demonstrated that AME
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together with postweaning WD impairs learning and
memory function in adult male mice [7]. Unfortunately,
how early life insults affect cognition functions later in life
remain poorly understood. One important mechanism is
epigenetic changes which can occur in response to environmental exposure [8]. Epigenetic changes include
DNA methylation, histone modifications, and micro
RNAs (miRs). Interestingly, miRs are key players in epigenetic regulation under stress condition [9]. Furthermore, miRs have been shown to affect cognitive function
in neurodegenerative disorders [10–12].
miRs act as key regulators of different biological functions including neurogenesis. miRs can indirectly influence neurogenesis by regulating the proliferation and
self-renewal of neural stem cells [13]. Importantly, decreased neurogenesis and neuronal death in the hippocampus are the characteristics of impaired cognitive
function [14–17]. Furthermore, regulation of hippocampal neurogenesis depends in part upon brain-derived
neurotrophic factor (BDNF) levels. BDNF is a member of
the neurotrophic family of growth factors and acts to support the survival of existing neurons, promote neuronal
differentiation, and maturation of newborn neurons [18,
19]. Reductions in the levels of BDNF have been shown
to significantly impair the production of new neurons
[20–24], whereas its direct infusion into the hippocampus
has been demonstrated to increase neurogenesis [25]. In
addition, BDNF protects hippocampal neurons against
apoptosis [19]. Interestingly, BDNF also is a target of
miRs [26].
miRs are gene expression modulators, acting at the
posttranscriptional level, and fine-tuning the expression
of protein-encoding genes. miRs modulate gene expression by binding to 3′ untranslated region (3′ UTR) of target mRNAs and leading to translational inhibition or
mRNA degradation [27, 28]. The BDNF gene 3′ UTR region contains numerous target sites for miRNA binding,
which have been confirmed for miRNA-BDNF interactions [29]. BDNF protein levels have been shown to negatively correlate with miRs expression [27–30]. For example, miR-1, miR-10b, miR-155, and miR-191 were
found to directly repress BDNF through binding to their
predicted sites in BDNF 3′ UTR [26]. Specifically, overexpression of miR-1 and miR-10b both suppressed BDNF
protein levels while mutations of their binding sites prevented repression [29].
miRs are short single-stranded noncoding RNAs
about 22 nucleotides in length. Mature miRs are generated from pre-miRs either 5′ arm or 3′ arm. The 5′ arm of
the miRNA is designated miR-5p present in the forward
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(5'-3') position, while the 3′ arm is miR-3p located in the
reverse position. Both are functional. Like protein-coding
genes, regulation of miRs’ expression involves epigenetic
mechanisms [31–33]. DNA hypermethylation at the promoter region leads to miR silencing [34, 35]. Histone
modifications, including histone acetylation (ac) and
methylation, affect gene transcription. For example, histone H3 lysine (K) 9ac, H3K14ac, and H3K4 trimethylation (me3) are often associated with gene activation,
while H3K36me3 is associated with actively transcribed
regions [36, 37]. Moreover, H3K9me3 and H3K27me3
are associated with gene silencing [36]. These histone
marks are also vulnerable to early life insults [38, 39].
However, the effects of AME on miRs’ expression and
their epigenetic profile in the hippocampus are unknown.
Understanding the effects of AME on hippocampal miRs’
expression may provide mechanistic insight into the regulation of hippocampal neurogenesis and subsequent
cognitive impairment. We therefore hypothesized that
AME would alter the expression of miRs in the hippocampus. We further hypothesized that changes in miRs’
expression would be associated with alterations in miR
epigenetic patterns, decreased hippocampal neurogenesis, and decreased BDNF levels.
Methods
Animals
All experiments were conducted according to the Public Health
Services Policy on Human Care and Use of Laboratory Animals
and all procedures were approved by the Medical College of Wisconsin Institutional Animal Care and Use Committee [40]. The
mouse model of AME used in this study has been previously described [41]. Briefly, AME was induced in mice by exposing sixweek-old C57/Bl6 female mice randomly to either a control diet
(10% fat without cholesterol and sucrose, Research Diet Inc., New
Brunswick, NJ, USA, Product# D14020502) or a WD (40% fat,
composed of increased saturated fat, cholesterol, and sucrose, Research Diet Inc., Product# D12079B) for 5 weeks prior to pregnancy and throughout lactation. Dams in the control diet group
experienced a normal environment throughout pregnancy and are
designated as control (Con). Dams fed a WD experienced a
“stressed” environment in the last third of pregnancy. The combination of chronic WD and gestational stress is designated as AME.
The stressed environment consisted of daily random environmental changes as well as a static change in the maternal environment
consisting of 1/3 of the standard amount of bedding from embryonic day (E) 13–E19. The acute random environmental changes
included altered light cycles on 3 nonconsecutive days, 3 repeat
cages throughout the day on E15, and the short-term introduction
of a novel object in the cage for a day. The period of prenatal stress
was limited to E13–E19 to minimize newborn mortality, avoid interference with implantation, and still target a period of rapid development and environmental vulnerability. Dams delivered
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Table 1. Primers for pyrosequencing

Set 1
Set 2
Set 3
Set 4

Forward

Reverse

Sequencing

5′ GATAGTTTTAGTTTAGGGAGGTT
5′ GGGTTTTTGTTTTTTTTTGGGAAATATT
5′ AAGAAGGTTTTGGTTGTTTAGT
5′ TTTGAATGTTTGTTTTGGGTAGG

5′ Biosg/ATAAATAATCACAACTAATCCTCCTAAAA
5′ Biosg/AACTAAACAACCAAAACCTTCT
5′ Biosg/CTACCAAACCTAATCTCTTCAACACA
5′ Biosg/ATCTATAACTATATAAATACCACACAAATT

5′ AGTAGTAGTTATAGTAGTAGTAGA
5′ GGAGATTTGGGTTTTGA
5′ GGTGGTTTTTATTTTGGTAA
5′ GTTTGTTTTGGGTAGGA

Table 2. Primers for ChIP assays

miR-10b promoter
Intergenic region

Forward

Reverse

Probe

5′ CTACCTGCACCATCTCTGAAAG
5′ TTTGGAACCACCATTTTCTACGT

5′ TCCTACCCAGAGCAGACATT
5′ GCTCAATAGATTTGATGGGCTTACT

5′ ACCTGATCTCTTCAGCACAGCCAC
5′ ACACCAGGCACTATT

ChIP, chromatin immunoprecipitation; miR, microRNA.

spontaneously, and litters were culled to 6 pups. At postnatal day
21 (P21), male pups from both Con and AME groups were anesthetized and killed. Brains were quickly removed, hippocampi
were dissected, flash frozen in liquid nitrogen, and stored in −80°C
for molecular studies. For immunohistochemistry studies, animals
were individually fixed via intracardiac perfusion with ice-cold
0.9% normal saline (VWR, Radnor, PA, USA), followed by icecold 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) for 5 min each for a total volume of 10–15 mL
fixative. Whole brains were removed and postfixed at 4°C overnight. Brains were then transferred to 70% ethanol, paraffin embedded, and sectioned coronally at 4 μm per section. The reason
for choosing to study juvenile hippocampus was because we wanted to examine immediate maternal effect on neurogenesis and its
regulation in the hippocampus. A total of 40 pregnant female mice
were used in the study with N = 6 dams per group.
RNA Isolation and Real Time RT-PCR
Total hippocampal RNA was extracted from P21 old mice using miRNeasy Micro Kit (Qiagen, Germantown, MD, USA) and
quantified using the BioTek Cytation 5 microplate reader (Fisher
Scientific Inc., Pittsburgh, PA, USA). RNA was treated with DNase
I (Ambion, Austin, TX, USA). Gel electrophoresis was used to confirm the integrity of the samples. miR cDNAs were synthesized
from total RNA using TaqMan® Advanced miRNA cDNA Synthesis Kit (Thermo Fisher Scientific). Real-time PCR for miRNA
assays were performed according to TaqMan® advanced miRNA
assays user guide using ABI ViiA7 system (Thermo Fisher Scientific). Relative quantification of PCR products was based on value
differences between the target and internal control using the comparative CT method (Taqman Gold RT-PCR manual, PE Biosystems, Foster City, CA, USA). Cycle parameters were 50°C, 2 min;
95°C, 10 min; and then 40 cycles at 95°C, 15 s; 60°C, 60 s. For each
set of reactions, samples were run in quadruplicate. Expression
levels of miRs known to affect cognitive function and BDNF levels
[26, 42–44] were tested, including miR-1a-3p (mmu482914_mir),
miR-10b-5p (mmu478494_mir), miR-10b-3p (mmu481501_mir),
miR-155-5p (mmu480953_mir), miR-155-3p (mmu481328_mir),
miR-183-5p (mmu482690_mir), miR-191-5p (mmu481584_mir),
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miR-191-3p (mmu480970_mir), and miR-206-3p (mmu481645_
mir). Expression was calculated relative to hsa-miR-320a (478594mir, TaqMan® advanced miRNA assays user guide, Thermo Fisher Scientific) which was used as an internal control. cDNA synthesis and real-time RT-PCR were performed as previously described
[45]. mRNA expression of BDNF (Mm04230607_s1, Thermo
Fisher Scientific) was calculated relative to hypoxanthine phosphoribosyltransferase 1 (HPRT1, Mm. PT.39a.22214828, Integrated DNA Technologies) which was used as an internal control.
DNA Isolation and Pyrosequencing
Hippocampal DNA was extracted from P21 old mice using
DNeasy® Blood & Tissue kit (Qiagen, Cat#69504). DNA was subjected to sodium bisulfite treatment using Epitech fast DNA bisulfite kit (Qiagen, Cat#59824) as per the manufacturer’s protocol to
determine site-specific CpG methylation. DNA methylation of the
validation-set samples was determined through PCR amplification
with biotinylated primers (Intergrated DNA Technologies,
Coralville, IA, USA). Primers were designed based on the genomic sequence obtained from Ensembl Genome Browser (Ensembl:
ENSMUSG00000065500) using PyroMark Assay Design Software
version 2.0. Amplified products were confirmed with agarose gel
electrophoresis. The percent of methylation was quantified by PyroMark Q48 Autoprep Pyrosequencer (Qiagen, Valencia, CA,
USA). Four primer sets (Table 1) were used to examine methylation status of 12 CpG sites in the promoter region of miR-10b,
spanning from −1 to −540bp nucleotide position from transcription start site which was set as +1.
Chromatin Isolation and Chromatin Immunoprecipitation
Assay
Hippocampal chromatin was isolated from P21 old mice using
truChIPTM chromatin shearing tissue kit (#520237, Covaris Inc,
MA, USA) and focused-ultrasonicator M220 (Covaris Inc.). Chromatin immunoprecipitation (ChIP) assays with antibodies against
histone H3 lysine (K) 4 trimethylation (H3K4me3, #9751, Cell Signaling Technology), H3K9me3 (#13969, Cell Signaling Technology), H3K27me3 (#9733, Cell Signaling Technology), H3K36me3
(#4909, Cell Signaling Technology), H3K9ac (#9649, Cell Signal-
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Fig. 1. AME increased miR-10b-5p levels in the hippocampus. Data are presented as mean ± SD. a miR levels.
b miR-191-5p levels. N = 6 animals from different litters/group. *p < 0.05. AME, adverse maternal environment;

Con, control; miR, microRNA.

ing Technology), and H3K14ac (#7627, Cell Signaling Technology) were performed using SimpleChIP® Plus Enzymatic Chromatin IP kit (#9005, Cell Signaling Technology). Real-time PCR was
used to quantitate the amount of immunoprecipitation DNA at
miR-10b promoter region and an intergenic region upstream of
IGF gene which was used as an internal control [46]. Primers for
miR-10b promoter and the intergenic region are list in Table 2.
Two control experiments were performed simultaneously with our
ChIP experiments. First, we performed a “mock” ChIP that included input but did not utilize antibody. Second, we performed a
ChIP that utilized an anti-rabbit secondary antibody as negative
control. Two percent of input was used as loading control.
Immunofluorescence
Immunofluorescent triple labeling was used to compare neurogenesis in dentate gyrus (DG) region of hippocampus between
Con and AME groups using cell proliferation marker Ki67 (#9129,
Cell Signaling, Danvers, MA, USA), neuronal differentiation
marker NeuroD1 (ab60704, Abcam, Cambridge, MA, USA), immature neuronal marker doublecortin (DCX, #4604, Cell Signaling, Danvers, MA, USA), and neuronal marker (NeuN, EMD Millipore, Billerica, MA, USA, Cat#MAB377). Briefly, anterior hippocampal coronal sections around bregma −1.94 area from the
same brains were deparaffinized, rehydrated, and subject to antigen retrieval treatment. Sections were then blocked with Protein
Block (DAKO, Carpinteria, CA, USA, Cat #x090930-2) for 30 min
at room temperature (RT) and followed by incubation with either
a mixture of rabbit anti-Ki67 1:200 and mouse anti-NeuN or a
mixture of rabbit anti-DCX 1:200 and mouse anti-NeuroD11:750
for 60 min at RT. After washing in TBST twice, sections were then
exposed to a mixture of donkey anti-rabbit AF488 1:750 and donkey anti-mouse Cy3 (Jackson ImmunoResearch) 1:750 or a mixture of donkey anti-rabbit Cy3 and donkey anti-mouse Cy51:750
for 45 min at RT. Followed by washing in TBST twice, sections
were counterstained for nuclei with DAPI. Sections were washed
and mounted with Prolong Gold anti-fade mounting media. Images were captured by confocal microscopy (Carl Zeiss LSM510,
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Jena, Germany). Positive cells for Ki67, NeuroD1, DCX, NeuN,
and DAPI staining on the digital images with ×20 magnification
were automated counted by ImageJ software. Two sections/pup, 5
animals from different litters per group were blindly quantified.
The counts for Ki67+, NeuroD1+, and NeuN+ were normalized to
DAPI count while DCX+ count was normalized to DAPI total
area.
Terminal Deoxynucleotidyl Transferase dUTP Nick End
Labeling
Apoptosis in the DG region of hippocampus from P21 Con and
AME brain was determined using DeadEndTM Fluorometric TUNEL System (G3250, Promega, Madison, WI, USA). In brief, anterior hippocampal coronal sections around bregma −1.94 area
were deparaffinized, rehydrated, and subject to terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) following the manufacturer’s instructions. Images were captured by confocal microscopy (Carl Zeiss LSM510, Jena, Germany). TUNEL
positive cells on the digital images with ×20 magnification were
automated counted by ImageJ software and normalized by DAPI
count. Two sections/pup, n = 5 animals from different litters per
group were blindly quantified.
Protein Isolation and Immunoblot
Hippocampal tissues from P21 old mice were homogenized in
ice-cold RIPA lysis buffer (Amresco LLC, Solon, OH, USA) with
protease and phosphatase inhibitors. After centrifugation at 10,000
rpm at 4°C for 15 min, the supernatants were removed and stored
at −80°C until use. Protein concentrations were determined by the
BCA method (Pierce, Rockford, IL, USA). Antibody against BDNF
(ThermoFisher Scientific, Cat# 710306) at 1:500 dilution was used
to determine protein abundance and vinculin (Cell Signaling, Cat
#13901) at 1:20,000 dilution was used as a loading control. Immunoblot analyses were performed by a capillary immunoblot analysis method using the ProteinSimpleTM Wes system according to the
manufacturer’s instructions (ProteinSimpleTM, Santa Clara, CA,
USA) as previously described [45].
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Fig. 2. AME altered BDNF expression in the hippocampus. Data are presented as mean ± SD. a BDNF mRNA
levels in Con versus AME mice. b BDNF protein levels in Con versus AME mice. N = 6 animals from different

litters/group. *p < 0.05, **p < 0.01. AME, adverse maternal environment; BDNF, brain-derived neurotropic factor; Con, control.
Statistics
GraphPad Prism 6 (GraphPad Software, San Diego, CA) was
used to perform all analyses. All data presented are expressed as
mean ± SD. ANOVA (Fisher’s protected least significant difference) and Mann-Whitney test determined statistical significance.
Significance was set as p < 0.05.

Results

AME Increased Hippocampal miR-10b-5p Levels
We first examined the effect of AME on miRs’ profile.
Interestingly, AME significantly increased hippocampal
miR-10b-5p levels but not other miRs that were examined (shown in Fig. 1a, b). Given that BDNF is a direct
target of miR-10b-5p, as well as a critical player in neuronal function, we then next determined BDNF expression
in the hippocampus.
AME Decreased Hippocampal BDNF Protein
Abundance
AME significantly decreased hippocampal BDNF protein abundance (shown in Fig. 2b) though AME increased
BDNF mRNA levels (shown in Fig. 2a). However, the
contrary results between BDNF protein and mRNA levels
suggest that miR-driven posttranscriptional regulation
may be involved in BDNF protein production. SpecifiAME Alters MicroRNA-10b-5p
Expression and Its Epigenetic Profile

cally, increased miR-10b-5p may contribute to reduced
BDNF protein levels in our model.
AME Decreased Neurogenesis and Increased
Apoptosis in Hippocampal DG Region
Both miRs and BDNF are key regulators of neurogenesis [13]. Importantly, impaired hippocampal neurogenesis and apoptosis are characteristics of cognitive impairment [16, 17]. Furthermore, hippocampal neurogenesis
postnatally occurs at the subgranular zone in the DG region of hippocampus [47, 48]. We then examined the effect of AME on neurogenesis in hippocampal DG region.
We found that AME significantly decreased neurogenesis
as indicated by decreased staining of Ki67+ (shown in
Fig. 3a, b), NeuroD1+ (Fig. 3c, d), NeuN+ (shown in
Fig. 3g, h) and trending to decrease DCX+ staining (shown
in Fig. 3e, f) in the DG region. We next determined the
effect of AME on apoptosis in the hippocampus using
TUNEL assay. We found that AME significantly increased apoptotic cell numbers in the DG region of hippocampus compared to Con (shown in Fig. 3i, j).
AME Altered Epigenetic Characteristics at miR-10b
Promoter in the Hippocampus
Like a protein-coding gene, miR expression can be epigenetically regulated [31–33]. Additionally, measurable
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epigenetic changes often occur in effected genes following an adverse early life environment [41]. We then determined the effect of AME on DNA methylation status
and histone code at miR-10b promoter.
AME significantly decreased CpG methylation at 5 out
of 12 sites (−9, −20, −175, −496, and −511 relative to transcription start site) examined at miR-10b promoter compared to Con (shown in Fig. 4). Furthermore, AME significantly increased the densities of active histone marks
H3K4me3, H3K14ac, and H3K36me3 at miR-10b promoter compared to Con with no effect on the densities of
H3K9ac, H3K9me3, and H3K27me3 (shown in Fig. 5a,
b). These data suggest that DNA methylation and histone
H3 modifications are involved in miR-10b-5p upregulation.
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Fig. 3. AME decreased neurogenesis and increased apoptosis in
hippocampal DG region. a Cell proliferation marker Ki67 staining
(green) in DG of Con (left panel) and AME (right panel) mice.
b Quantitative analysis of Ki67+ cells in Con versus. AME mice.
c Neuronal differentiation marker NeuroD1 staining (pink) in DG
of Con (left panel) and AME (right panel) mice. d Quantitative
analysis of NeuroD1+ cells in Con versus. AME mice. e Immature
neuronal marker DCX staining (red) in DG of Con (left panel) and
AME (right panel) mice. f Quantitative analysis of DCX+ cells in
Con versus. AME mice. g Neuronal marker NeuN staining (red)
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in DG of Con (left panel) and AME (right panel) mice. h Quantitative analysis of NeuN+ cells in Con versus. AME mice. i TUNEL
assay showing apoptotic cells (green) in hippocampal DG region
of Con (left panel) and AME (right panel) mice. j Quantitative
analysis of apoptotic cells in Con versus. AME mice. Data are presented as mean ± SD, n = 5 animals from different litters/group.
*p < 0.05, Scale bar = 100 μm. AME, adverse maternal environment; DG, dentate gyrus; TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end labeling; Con, control.

Discussion

The novel findings of this study are that AME increased miR-10b-5p levels concurrently with decreased
BDNF protein abundance and impaired neurogenesis in
mouse hippocampus. In addition, increased miR-10b-5p
levels were associated with altered epigenetic profile at its
promoter. These findings suggest that early life stress and
diet endured by the mother affect miR-10b-5p expression
via epigenetic mechanism and subsequently alter BDNF
levels in the hippocampus, which in turn affect hippocampal neurogenesis and lead to cognitive impairment
later in life. To our knowledge, this is the first report that
AME affects the epigenetic profile and expression of miR10b-5p concurrently with neurogenesis impairment in
offspring hippocampus.
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of mouse miR-10b proximal promoter. Vertical lines indicate the location of the CpG sites examined relative to
translation start site set as +1. b Percent of methylation at 12 CpG sites examined. Data are presented as mean ±
SD. N = 6 animals from different litters/group. *p < 0.05. AME, adverse maternal environment; miR, microRNA;
Con, control.

Fig. 5. AME increased active histone marks at miR-10b promoter. a The densities of H3K4me3, H3K9ac,
H3K9me3, H3K14ac, H3K27me3, and H3K36me3 were quantified relative to 2% input by ChIP assay. b The

densities of H3K4me3, H3K9ac, H3K9me3, H3K14ac, H3K27me3, and H3K36me3 relative to intergenic region.
Data are presented as mean ± SD n = 6 animals from different litters/group. *p < 0.05. AME, adverse maternal
environment; ChIP, chromatin immunoprecipitation; K, lysine; me3, trimethylation; ac, acetylation.
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AME has a profound impact on hippocampal structure and function that subsequently leads to cognitive impairment through epigenetic mechanisms [49]. miRs are
key players in epigenetic regulations which often occur in
response to environmental exposure and under stress
condition [8, 9, 50]. Altered miR expression has been
found in the key brain regions related to cognitive function including hippocampus following exposure to early
life stress in both humans and animals [9, 50–52]. However, no studies have reported the relationship between
early life stress and miR-10b in the hippocampus. In current study, we found that miR-10b-5p levels were significantly increased in the hippocampus of pups exposed to
AME. Our data suggest that upregulated miR-10b-5p expression may play a role in the cognitive impairment previously reported in our model [41].
miRs are gene expression modulators and act at the
posttranscriptional level to control protein production of
target genes [27, 28]. miR-10b targets the cognition network gene BDNF and is negatively correlated with BDNF
levels [53, 54]. For example, Jiang and Zhu [55] have
demonstrated that BDNF is a direct target of miR-10b
and BDNF expression negatively correlates with the expression of miR-10b in rat hippocampus under chronic
stress depression induced by sleep deprivation. Furthermore, BDNF levels have been shown to be posttranscriptionally controlled by upregulated miR-10b-5p in human
prefrontal cortex of Huntington disease brain [54].
Whereas no studies have reported the relationship between miR-10b-5p and BDNF in the hippocampus exposed to early life stress. In this study, we found that AME
decreased BDNF protein abundance in line with increased miR-10b-5p levels in the hippocampus, suggesting that miR-10b-5p may target BDNF and decrease
BDNF protein levels in our model.
BDNF regulates neuronal survival and differentiation
[56]. Reduced BDNF expression is associated with neuronal dysfunction and death [48, 49, 57, 58]. Here, we
found that AME-induced hippocampal BDNF protein reduction coincides with impaired neurogenesis by decreasing cell proliferation, neuronal differentiation, and
mature neuron numbers, as well as increased apoptosis in
the hippocampus. Similar findings have been reported in
the hippocampus of offspring exposed to other early life
stress in animal models [43, 48, 57, 58]. Although maternal WD alone has been shown to have negative effects on
BDNF expression and neurogenesis in offspring hippocampus [59, 60], our AME model consists a maternal WD
component and did not affect cognitive function in adult
animals [7]. We suggest that BDNF protein reduction and
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neurogenesis impairment seen in our model may result
from the effects of the combination of maternal WD and
prenatal stress.
miRs’ expression can be regulated epigenetically [61].
DNA hypermethylation at the promoter region has been
shown to lead to miR silencing [34, 35]. Specifically, DNA
CpG methylation in a transcription factor binding site of
miR-10b leads to downregulation in a human cervical
cancer cell line [62]. Inversely, in our study, we found that
AME decreased DNA methylation at limited CpG sites of
miR-10b promoter in the hippocampus concurrently
with increased miR-10b-5p expression. Interestingly, the
promoter region examined in this current study contains
a Sp1 binding element at the −324 site examined here. Sp1
is typically a transcriptional activator [63] and enhances
transcription by RNA polymerase II [64]. miR genes are
transcribed by RNA polymerase II [65]. We speculate that
decreased CpG methylation at miR-10b promoter around
Sp1 binding site may facilitate Sp1 binding and RNA
polymerase II transcriptional machinery assembling and
subsequently lead to miR-10b-5p transcriptional activation. Future studies are warranted to explore the role of
TFs including Sp1 on miR-10b transcription.
Interestingly, we also found that AME significantly increased accumulations of active histone marks
H3K4me3, H3K14ac, and H3K36me3 at the promoter
region of miR-10b. Our data suggest that multiple histone modifications are involved in the regulation of miR10b-5p expression. Though early epigenetic studies focused on the consequences of single-site histone modifications, it is now evident that modifications at different
sites influence their effect on transcription, which involves simultaneously reading multiple histone markers
[66]. Different histone marks may interact with each other to affect gene transcription. For example, H3K4me3
has been shown to intricately link acetylation at H3K14
by recruiting Ybg1 PHD finger binding and stabilizing
the interaction of the scNuA3 HAT leading to hyperacetylation of its substrate [67]. In addition, while H3K36me3
has been observed to be more enriched at body regions
of active genes and related to transcriptional elongation
[68, 69], H3K36me3 has also been shown to be involved
in transcriptional initiation [69, 70]. Specifically, Zhang
et al. [70] have shown that H3K36me3 mediated by its
methyltransferase Setd2 was enriched at a distal promoter region of a gene of interest and led to transcriptional
initiation. Taken together, our data suggest that accumulations of H3K4me3, H3K14ac, and H3K36me3 to miR10b promoter may work together to favor miR-10b-5p
transcription.
Ke/Huang/Fu/Lane/Majnik

Our study has limitations. Whether AME-induced upregulation of miR-10b-5p directly affects BDNF protein
production and subsequently impairs neurogenesis in developing hippocampal DG requires further investigations.
Moreover, maternal WD or prenatal stress alone may affect epigenetic profile of miR-10b promoter and subsequently alter mir-10b-5p expression, which have not been
examined in this study. Additionally, how prenatal maternal stress affects postnatal maternal care behavior and
subsequent offspring DG development, as well as how epigenetic changes are maintained during neural stem cell
proliferation have not been revealed. All molecular analysis performed in this study utilized whole homogenized
hippocampus, thus limiting our ability to understand the
contribution of hippocampal subfields but allowed for a
comprehensive hippocampal investigation. Last, we recognize that we do not know whether AME-induced upregulation of miR-10b-5p occurs in female offspring, who
do not suffer similar cognitive impairment relative to the
male counterparts. If AME did not induce upregulation of
miR-10b-5p in females, this finding would add circumstantial support to our speculation.
In this study, we have identified that AME increased
miR-10b-5p levels concurrently with decreased BDNF
protein levels and neurogenesis as well as increased apoptosis in juvenile mouse hippocampus. We speculate that
AME increases miR-10b-5p levels by altering epigenetic
profile at the promoter region of miR-10b. Increased
miR-10b-5p subsequently acts on BDNF to reduce BDNF
protein production and leads to decreased neurogenesis
in juvenile mouse hippocampus.
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